Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04641754
Status:
UNKNOWN
Last Update Posted:
2020-11-24
First Post:
2020-11-11
Brief Title:
A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive or ROS1-positive Non-small Cell Lung Cancer
Sponsor:
Qilu Pharmaceutical Co Ltd
Organization:
Qilu Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-11
First Submit QC Date:
November 17 2020
Study First Post Date:
2020-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-17
Last Update Post Date:
2020-11-24
Last Update Post Date Type:
ACTUAL